Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
   21  Cardiovascular agents
   22  Respiratory organ agents
   23  Digestive organ agents
   24  Hormones
   25  Urogenital and anal organ agents
   26  Epidermides
     261  Antimicrobial agents
       2611  Chlorates
       2612  Iodates
       2613  Borates
       2614  Peroxides
       2615  Alcohols
         D00137  Isopropyl alcohol (USP); Isopropanol (JP17)
         D00068  Alcohol (USP); Anhydrous ethanol (JP17)
         D04855  Ethanol for disinfection (JP17)
         D06542  Ethanol (JP17)
         D04732  Isopropanol and methylated alcohol
D08AX05
D08AX08 V03AB16 V03AZ01
D08AX08 V03AB16 V03AZ01
D08AX08 V03AB16 V03AZ01
 
       2616  Medical soaps
       2619  Others
     262  Skin protectants
     263  Suppurative dermatosis agents
     264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
     265  Antiparasitic dermatosis agents
     266  Emollients
     267  Hair remedies
     268  Bath preparations
     269  Miscellaneous
   27  Dental preparations
   29  Other agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
     423  Antibiotics
     424  Plant extract preparations
     429  Miscellaneous
       4291  Other Antitumors
         D00068  Alcohol (USP); Anhydrous ethanol (JP17)
         D00094  Tretinoin (JAN/USP/INN)
         D01370  Cladribine (JAN/USP/INN)
         D03021  Azacitidine (JAN/USAN/INN)
         D06199  Trabectedin (JAN/USAN/INN)
         D02166  Mitoxantrone hydrochloride (JAN/USP)
         D01441  Imatinib mesylate (USAN); Imatinib mesilate (JAN)
         D06414  Dasatinib (USAN); Dasatinib hydrate (JAN)
         D06413  Nilotinib hydrochloride hydrate (JAN)
         D09728  Bosutinib hydrate (JAN)
         D09951  Ponatinib hydrochloride (JAN/USAN)
         D01977  Gefitinib (JAN/USAN/INN)
         D04023  Erlotinib hydrochloride (JAN/USAN)
         D09733  Afatinib dimaleate (USAN); Afatinib maleate (JAN)
         D10766  Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
         D10514  Dacomitinib (USAN); Dacomitinib hydrate (JAN)
         D09996  Vemurafenib (JAN/USAN/INN)
         D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)
         D11053  Encorafenib (JAN/USAN/INN)
         D09731  Crizotinib (JAN/USAN/INN)
         D10551  Ceritinib (JAN/USAN/INN)
         D10450  Alectinib hydrochloride (JAN)
         D11012  Lorlatinib (JAN/USAN/INN)
         D10176  Trametinib dimethyl sulfoxide (JAN/USAN)
         D10604  Binimetinib (JAN/USAN)
         D10372  Palbociclib (JAN/USAN)
         D10688  Abemaciclib (JAN/USAN)
         D06068  Temsirolimus (JAN/USAN/INN)
         D02714  Everolimus (JAN/USAN/INN)
         D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
         D09960  Ruxolitinib phosphate (JAN/USAN)
         D03218  Axitinib (JAN/USAN)
         D10223  Ibrutinib (JAN/USAN)
         D06402  Sunitinib malate (JAN/USAN)
         D06272  Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)
         D05380  Pazopanib hydrochloride (JAN/USAN)
         D06407  Vandetanib (JAN/USAN/INN)
         D10137  Regorafenib hydrate (JAN)
         D10095  Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)
         D09920  Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)
         D09956  Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)
         D10800  Gilteritinib fumarate (JAN/USAN)
         D10926  Entrectinib (JAN/USAN/INN)
         D10891  Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN)
         D11073  Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)
         D00275  Cisplatin (JP17/USP/INN)
         D01363  Carboplatin (JP17/USP/INN)
         D01790  Oxaliplatin (JAN/USP/INN)
         D00478  Procarbazine hydrochloride (JP17/USP)
         D02994  Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)
         D03257  Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN)
         D03455  Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)
         D06409  Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
         D05350  Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)
         D09314  Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN)
         D04603  Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)
         D09587  Brentuximab vedotin (USAN); Brentuximab vedotin (genetical recombination) (JAN)
         D05446  Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN)
         D09980  Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN)
         D09321  Obinutuzumab (USAN); Obinutuzumab (genetical recombination) (JAN)
         D10316  Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)
         D10574  Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)
         D09325  Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN)
         D09371  Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN)
         D10018  Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN)
         D09337  Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
         D10777  Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)
         D09761  Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN)
         D10808  Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN)
         D10817  Avelumab (USAN); Avelumab (genetical recombination) (JAN)
         D10773  Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)
         D11050  Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN)
         D11529  Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN)
         D03106  Bexarotene (JAN/USAN/INN)
         D03150  Bortezomib (JAN/USAN/INN)
         D08880  Carfilzomib (JAN/USAN/INN)
         D10131  Ixazomib citrate (JAN/USAN)
         D06320  Vorinostat (JAN/USAN)
         D06637  Romidepsin (JAN/USAN/INN)
         D10019  Panobinostat lactate (JAN)
         D09730  Olaparib (JAN/USAN/INN)
         D11895  Niraparib tosilate hydrate (JAN)
         D02997  Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
         D00155  Pentostatin (JAN/USAN/INN)
         D02106  Arsenic trioxide (JP17/USAN)
         D08914  Eribulin mesylate (USAN); Eribulin mesilate (JAN)
         D10679  Venetoclax (JAN/USAN/INN)
         D00966  Tamoxifen citrate (JP17/USP)
         D00967  Toremifene citrate (JAN/USAN)
         D01161  Fulvestrant (JAN/USP/INN)
         D00586  Flutamide (JP17/USP/INN)
         D00961  Bicalutamide (JAN/USP/INN)
         D10218  Enzalutamide (JAN/USAN)
         D11040  Apalutamide (JAN/INN)
         D11045  Darolutamide (JAN/USAN/INN)
         D00960  Anastrozole (JAN/USP/INN)
         D00964  Letrozole (JAN/USP/INN)
         D00963  Exemestane (JAN/USP/INN)
         D09701  Abiraterone acetate (JAN/USP)
         D00753  Sirolimus (JAN/USAN/INN)
         D02802  Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN)
         D00754  Thalidomide (JAN/USP/INN)
         D09813  Lenalidomide hydrate (JAN)
         D08976  Pomalidomide (JAN/USAN/INN)
         D04489  Ibritumomab tiuxetan (USAN/INN); Ibritumomab tiuxetan (genetical recombination) (JAN)
         D10398  Radium Ra 223 dichloride (USAN)
         D01404  Sobuzoxane (JAN)
         D01416  Nedaplatin (JAN/INN)
         D01418  Tamibarotene (JAN/INN)
         D04245  Forodesine hydrochloride (JAN/USAN)
         D06294  Miriplatin hydrate (JAN)
         D10819  Aflibercept beta (genetical recombination) (JAN)
         D11070  Tirabrutinib hydrochloride (JAN)
         D11272  Borofalan (10B) (JAN)
         D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)
D08AX08 V03AB16 V03AZ01
D10AD01 L01XF01
L01BB04 L04AA40
L01BC07
L01CX01
L01DB07
L01EA01
L01EA02
L01EA03
L01EA04
L01EA05
L01EB01
L01EB02
L01EB03
L01EB04
L01EB07
L01EC01
L01EC02
L01EC03
L01ED01
L01ED02
L01ED03
L01ED05
L01EE01
L01EE03
L01EF01
L01EF03
L01EG01
L01EG02 L04AA18
L01EH01
L01EJ01
L01EK01
L01EL01
L01EX01
L01EX02
L01EX03
L01EX04
L01EX05
L01EX07
L01EX08
L01EX11
L01EX13
L01EX14
L01EX17
L01EX21
L01XA01
L01XA02
L01XA03
L01XB01
L01XC02
L01XC03
L01XC06
L01XC07
L01XC08
L01XC10
L01XC11
L01XC12
L01XC13
L01XC14
L01XC15
L01XC17
L01XC18
L01XC19
L01XC21
L01XC22
L01XC23
L01XC24
L01XC25
L01XC28
L01XC31
L01XC32
L01XC38
L01XC41
L01XF03
L01XG01
L01XG02
L01XG03
L01XH01
L01XH02
L01XH03
L01XK01
L01XK02
L01XX02
L01XX08
L01XX27
L01XX41
L01XX52
L02BA01
L02BA02
L02BA03
L02BB01
L02BB03
L02BB04
L02BB05
L02BB06
L02BG03
L02BG04
L02BG06
L02BX03
L04AA10 S01XA23
L04AA34
L04AX02
L04AX04
L04AX06
V10XX02
V10XX03
 
 
 
 
 
 
 
 
 
       4299  Others
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: January 15, 2021
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version